Literature DB >> 30301826

Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models.

Mo Zhang1,2, Naoko Kobayashi1, Kirstin A Zettlitz3, Evelyn A Kono1, Joyce M Yamashiro1, Wen-Ting K Tsai3, Ziyue K Jiang1, Chau P Tran1, Chung Wang1, Johnny Guan1, Anna M Wu3, Robert E Reiter4.   

Abstract

PURPOSE: The inability to intraoperatively distinguish primary tumor, as well as lymphatic spread, increases the probability of positive surgical margins, tumor recurrence, and surgical toxicity. The goal of this study was to develop a tumor-specific optical probe for real-time fluorescence-guided surgery. EXPERIMENTAL
DESIGN: A humanized antibody fragment against PSCA (A11 minibody, A11 Mb) was conjugated with a near-infrared fluorophore, IRDye800CW. The integrity and binding of the probe to PSCA were confirmed by gel electrophoresis, size-exclusion chromatography, and flow cytometry, respectively. The ability of the probe to detect tumor-infiltrated lymph nodes and metastatic lesions was evaluated in 2 xenograft models, as well as in transgenic mice expressing human PSCA (hPSCA). An invasive intramuscular model was utilized to evaluate the efficacy of the A11 Mb-IRDye800CW-guided surgery.
RESULTS: A11 Mb was successfully conjugated with IRDye800CW and retained specific binding to PSCA. In vivo imaging showed maximal signal-to-background ratios at 48 hours. The A11 Mb-IRDye800CW specifically detected PSCA-positive primary tumors, tumor-infiltrated lymph nodes, and distant metastases with high contrast. Fluorescence guidance facilitated more complete tumor resection, reduced tumor recurrence, and improved overall survival, compared with conventional white light surgery. The probe successfully identified primary orthotopic tumors and metastatic lesions in hPSCA transgenic mice.
CONCLUSIONS: Real-time fluorescence image-guided surgery with A11 Mb-IRDye800CW enabled detection of lymph node metastases and positive surgical margins, facilitated more complete tumor removal, and improved survival, compared with white light surgery. These results may be translatable into clinical practice to improve surgical and patient outcomes. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30301826      PMCID: PMC6559730          DOI: 10.1158/1078-0432.CCR-18-1382

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  9 in total

1.  Evaluation of [131I]I- and [177Lu]Lu-DTPA-A11 Minibody for Radioimmunotherapy in a Preclinical Model of PSCA-Expressing Prostate Cancer.

Authors:  Wen-Ting K Tsai; Kirstin A Zettlitz; Magnus Dahlbom; Robert E Reiter; Anna M Wu
Journal:  Mol Imaging Biol       Date:  2020-10       Impact factor: 3.488

2.  [89Zr]A2cDb Immuno-PET of Prostate Cancer in a Human Prostate Stem Cell Antigen Knock-in (hPSCA KI) Syngeneic Model.

Authors:  Kirstin A Zettlitz; Wen-Ting K Tsai; Scott M Knowles; Felix B Salazar; Naoko Kobayashi; Robert E Reiter; Anna M Wu
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

3.  Novel Gastrin-Releasing Peptide Receptor Targeted Near-Infrared Fluorescence Dye for Image-Guided Surgery of Prostate Cancer.

Authors:  Amerigo Pagoto; Francesca Garello; Giada Maria Marini; Martina Tripepi; Francesca Arena; Paola Bardini; Rachele Stefania; Stefania Lanzardo; Giovanni Valbusa; Francesco Porpiglia; Matteo Manfredi; Silvio Aime; Enzo Terreno
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

Review 4.  Fundamentals and developments in fluorescence-guided cancer surgery.

Authors:  J Sven D Mieog; Friso B Achterberg; Aimen Zlitni; Merlijn Hutteman; Jacobus Burggraaf; Rutger-Jan Swijnenburg; Sylvain Gioux; Alexander L Vahrmeijer
Journal:  Nat Rev Clin Oncol       Date:  2021-09-07       Impact factor: 66.675

5.  Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity.

Authors:  John P Murad; Dileshni Tilakawardane; Anthony K Park; Lupita S Lopez; Cari A Young; Jackson Gibson; Yukiko Yamaguchi; Hee Jun Lee; Kelly T Kennewick; Brenna J Gittins; Wen-Chung Chang; Chau P Tran; Catalina Martinez; Anna M Wu; Robert E Reiter; Tanya B Dorff; Stephen J Forman; Saul J Priceman
Journal:  Mol Ther       Date:  2021-02-27       Impact factor: 12.910

Review 6.  Unique Benefits of Tumor-Specific Nanobodies for Fluorescence Guided Surgery.

Authors:  Thinzar M Lwin; Robert M Hoffman; Michael Bouvet
Journal:  Biomolecules       Date:  2021-02-18

7.  Development and Preclinical Evaluation of a Near-Infrared Fluorescence Probe Based on Tailored Hepatitis B Core Particles for Imaging-Guided Surgery in Breast Cancer.

Authors:  Lei Ren; Guo-Jun Zhang; Rui-Qin Yang; Min Chen; Qiang Zhang; Yi-Yang Gao; Kang-Liang Lou; Tong-Tong Lin; Wen-He Huang; Yun-Zhu Zeng; Yong-Qu Zhang; Yong-Ying Dang
Journal:  Int J Nanomedicine       Date:  2022-03-22

8.  Engineered Fragments of the PSMA-Specific 5D3 Antibody and Their Functional Characterization.

Authors:  Zora Novakova; Nikola Belousova; Catherine A Foss; Barbora Havlinova; Marketa Gresova; Gargi Das; Ala Lisok; Adam Prada; Marketa Barinkova; Martin Hubalek; Martin G Pomper; Cyril Barinka
Journal:  Int J Mol Sci       Date:  2020-09-12       Impact factor: 5.923

Review 9.  Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible.

Authors:  Thinzar M Lwin; Michael A Turner; Siamak Amirfakhri; Hiroto Nishino; Robert M Hoffman; Michael Bouvet
Journal:  Cells       Date:  2022-01-12       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.